Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data.
Virdee PS, Bankhead C, Koshiaris C, Drakesmith CW, Oke J, Withrow D, Swain S, Collins K, Chammas L, Tamm A, Zhu T, Morris E, Holt T, Birks J, Perera R, Hobbs FDR, Nicholson BD. Virdee PS, et al. Among authors: hobbs fdr. Diagn Progn Res. 2023 Jan 10;7(1):1. doi: 10.1186/s41512-022-00138-6. Diagn Progn Res. 2023. PMID: 36624489 Free PMC article.
Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19).
Nicholson BD, Turner PJ, Fanshawe TR, Williams AJ, Amirthalingam G, Tonner S, Zambon M, Body R, Davies K, Perera R, de Lusignan S, Hayward GN, Hobbs FDR; RAPTOR-C19 Study Group and the CONDOR Steering Committee. Nicholson BD, et al. Among authors: hobbs fdr. PLoS One. 2023 Jul 21;18(7):e0288612. doi: 10.1371/journal.pone.0288612. eCollection 2023. PLoS One. 2023. PMID: 37478103 Free PMC article. Clinical Trial.
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19).
Fanshawe TR, Tonner S, Turner PJ, Cogdale J, Glogowska M, de Lusignan S, Okusi C, Perera R, Sebastianpillai P, Williams A, Zambon M, Nicholson BD, Hobbs FDR, Hayward GN; RAPTOR-C19 Study Group. Fanshawe TR, et al. Among authors: hobbs fdr. Clin Microbiol Infect. 2024 Mar;30(3):380-386. doi: 10.1016/j.cmi.2023.12.009. Epub 2023 Dec 15. Clin Microbiol Infect. 2024. PMID: 38103638 Free article.
A targeted approach to vaccine hesitancy.
Leston M, de Lusignan S, Hobbs FDR. Leston M, et al. Among authors: hobbs fdr. Oxf Open Immunol. 2023 Oct 28;4(1):iqad007. doi: 10.1093/oxfimm/iqad007. eCollection 2023. Oxf Open Immunol. 2023. PMID: 38089637 Free PMC article.
Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial.
Hill NR, Lasserson D, Thompson B, Perera-Salazar R, Wolstenholme J, Bower P, Blakeman T, Fitzmaurice D, Little P, Feder G, Qureshi N, Taal M, Townend J, Ferro C, McManus R, Hobbs FDR. Hill NR, et al. Among authors: hobbs fdr. Trials. 2022 Dec 12;23(1):999. doi: 10.1186/s13063-022-06972-9. Trials. 2022. PMID: 36510220 Free PMC article. No abstract available.
Correction: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments.
Cake C, Ogburn E, Pinches H, Coleman G, Seymour D, Woodard F, Manohar S, Monsur M, Landray M, Dalton G, Morris AD, Chinnery PF; UK COVID-19 National Core Studies Consortium; Hobbs FDR, Butler C. Cake C, et al. Among authors: hobbs fdr. Trials. 2023 Sep 19;24(1):598. doi: 10.1186/s13063-023-07606-4. Trials. 2023. PMID: 37726825 Free PMC article. No abstract available.
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Bedston S, Almaghrabi F, Patterson L, Agrawal U, Woolford L, Anand SN, Joy M, Crawford A, Goudie R, Byford R, Abbasizanjani H, Smith D, Laidlaw L, Akbari A, Sullivan C, Bradley DT, Lyons RA, de Lusignan S, Hobbs FDR, Robertson C, Sheikh SA, Shi T. Bedston S, et al. Among authors: hobbs fdr. Lancet Reg Health Eur. 2023 Dec 12;37:100816. doi: 10.1016/j.lanepe.2023.100816. eCollection 2024 Feb. Lancet Reg Health Eur. 2023. PMID: 38162515 Free PMC article.
Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study.
Archer L, Koshiaris C, Lay-Flurrie S, Snell KIE, Riley RD, Stevens R, Banerjee A, Usher-Smith JA, Clegg A, Payne RA, Hobbs FDR, McManus RJ, Sheppard JP; STRAtifying Treatments In the multi-morbid Frail elderlY (STRATIFY) investigators. Archer L, et al. Among authors: hobbs fdr. BMJ. 2022 Nov 8;379:e070918. doi: 10.1136/bmj-2022-070918. BMJ. 2022. PMID: 36347531 Free PMC article.
320 results